Nicotine Spray + Placebo
Phase 3Completed 0 views this week 0 watching⚡ Active
Interest: 40/100
40
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Tobacco Dependence
Conditions
Tobacco Dependence
Trial Timeline
Jan 31, 2015 → Feb 10, 2016
NCT ID
NCT02355665About Nicotine Spray + Placebo
Nicotine Spray + Placebo is a phase 3 stage product being developed by Johnson & Johnson for Tobacco Dependence. The current trial status is completed. This product is registered under clinical trial identifier NCT02355665. Target conditions include Tobacco Dependence.
What happened to similar drugs?
7 of 9 similar drugs in Tobacco Dependence were approved
Approved (7) Terminated (3) Active (1)
Hype Score Breakdown
Clinical
17
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02355665 | Phase 3 | Completed |
Competing Products
20 competing products in Tobacco Dependence